NGT BioPharma Consultants provide early drug development services centered on fit-for-purpose approaches for small molecules and biologics (Mabs, duobodies, proteins, cell therapy, gene therapy, and new modalities), that are  designed to advance drug candidates, rapidly and efficiently, to the next important development milestone. Our diverse consultant expertise, which spans all the essential interdependent CMC, Regulatory, Quality, Nonclinical and Clinical disciplines, can be complemented with our highly experienced product leaders and project managers.